Plp1 gene expression occurs very early in development, well before the onset of myelination, creating a conundrum with regard to the function of myelin proteolipid protein (PLP), one of the major proteins in compact myelin. Using PLP-EGFP mice to investigate Plp1 promoter activity, we found that, at very early time points, PLP-EGFP was expressed in Sox2ϩ undifferentiated precursors in the spinal cord ventricular zone (VZ), as well as in the progenitors of both neuronal and glial lineages. As development progressed, most PLP-EGFPexpressing cells gave rise to oligodendrocyte progenitor cells (OPCs). The expression of PLP-EGFP in the spinal cord was quite dynamic during development. PLP-EGFP was highly expressed as cells delaminated from the VZ. Expression was downregulated as cells moved laterally through the cord, and then robustly upregulated as OPCs differentiated into mature myelinating oligodendrocytes. The presence of PLP-EGFP expression in OPCs raises the question of its role in this migratory population. We crossed PLP-EGFP reporter mice into a Plp1-null background to investigate the role of PLP in early OPC development. In the absence of PLP, normal numbers of OPCs were generated and their distribution throughout the spinal cord was unaffected. However, the orientation and length of OPC processes during migration was abnormal in Plp1-null mice, suggesting that PLP plays a role either in the structural integrity of OPC processes or in their response to extracellular cues that orient process outgrowth.
Introduction
Myelin proteolipid protein (PLP) is one of the most abundant components of the myelin sheath in the CNS, comprising ϳ50% of the total protein content (Eng et al., 1968) . Intriguingly, long before myelin production commences, transcripts encoding PLP, and its shorter isoform DM20, are expressed in a subset of progenitors (LeVine et al., 1990; Timsit et al., 1992; Dickinson et al., 1996) . Plp1-expressing cells give rise to oligodendrocytes and astrocytes, and to subtypes of thalamic and medullary neurons (Spassky et al., 1998; Delaunay et al., 2008; Guo et al., 2009; Miller et al., 2009; Michalski et al., 2011) . The function of this important myelin structural protein in neuronal and glial progenitors remains unclear, though our previous work (Gudz et al., 2002 (Gudz et al., , 2006 suggests PLP may integrate extracellular signals and regulate migratory behavior of oligodendrocyte progenitor cells (OPCs).
Previous studies investigated Plp1 expression in neuronal and glial progenitors by crossing Plp-Cre mice with floxed reporter strains. This permanently labels Plp1-expressing cells as well as their progeny, which may or may not continue to express Plp1 (Guo et al., 2009; Michalski et al., 2011) . By contrast, in PLP-EGFP mice, only cells currently expressing the Plp1 promoter were labeled (Mallon et al., 2002) . Thus, we were able to study the dynamics of Plp/Dm20 expression by tracking the migration and fates of embryonic and postnatal cells actively expressing PLP-EGFP. In agreement with earlier studies, both neuronal and glial precursors had robust Plp1 promoter activity at early embryonic stages (indicated by intense EGFP expression). In addition, migratory glial cells continued to display strong Plp1 promoter activity, which was then downregulated in astrocytes. OPCs also downregulated Plp1 promoter activity as they reached the lateral spinal cord, but then upregulated it significantly during postnatal myelination.
There has been debate about the origin of OPCs in the developing CNS, specifically whether early Plp-expressing and platelet-derived growth factor receptor ␣ (PDGFR␣)-expressing cells represent two distinct progenitor populations or different stages of a single progenitor (Spassky et al., 1998 (Spassky et al., , 2000 Richardson et al., 2000) . Here, we observed that initially all Olig2/PDGFR␣-expressing OPCs were PLP-EGFPϩ. As OPCs moved laterally through the developing spinal cord, PLP-EGFP was downregulated, leading to a mixed population of PLP-EGFPϩ/PDGFR␣Ϫ, PLP-EGFPϩ/ PDGFR␣ϩ, or PLP-EGFPϪ/PDGFR␣ϩ cells throughout the cord. Therefore, varying reports of the contributions of each "lineage" to the overall OPC population may have resulted from analyses of this mixed population.
While earlier studies established that the Plp1 promoter and mRNA are expressed in early progenitors (Timsit et al., 1992; Mallon et al., 2002) , we report that PLP/DM20 protein is also present in embryonic OPCs. To assess a role for PLP in early neuronal and glial progenitors, we examined their development in Plp1-null mice. During migration, processes of Plp1-null OPCs were disorganized, with many failing to adopt a radial orientation. However, despite abnormal process extension, neither OPC distribution nor the onset of myelination was disrupted in the absence of PLP/DM20.
Materials and Methods
Animals. Homozygous transgenic Plp-EGFP-3ЈUTR mice (PLP-EGFP; Mallon et al., 2002) were bred with Plp1-null mice (Klugmann et al., 1997) on a C57BL/6J background (Jackson Labs). The day of insemination, detected by a vaginal plug, was defined as embryonic day (E) 0.5. Embryonic sex (McClive and Sinclair, 2001) and Plp genotypes were determined by PCR as previously described. Plp1 is on the X chromosome; therefore males carrying the null allele express no PLP/DM20. Plp1-null and wild-type littermate males were used for experiments. All animal procedures were conducted with the approval of the University of Colorado Institutional Animal Care and Use Committee.
Immunostaining. The following primary antibodies were used: rat anti-PLP/DM20 monoclonal antibody (1:100; clone AA3; Yamamura et al., 1991) , rat anti-PDGFR␣ (1:400; BD PharMingen), rabbit anti-Olig2 (1: 10,000; a gift from Dr. Charles Stiles, Harvard University), mouse anti-NeuN (1:400; EMD Millipore), mouse anti-GFAP (1:600), mouse anti-S100␤ (1: 400), rabbit anti-S100␤ (1:500; Sigma-Aldrich), mouse anti-Nestin (1:120; Abcam), rabbit anti-Sox2 (1:1000; Millipore Bioscience Research Reagents). Pregnant females were killed via cervical dislocation; embryos were removed and immersion fixed in 4% paraformaldehyde in 0.1 M PBS (PFA) overnight at 4°C. Postnatal animals were transcardially perfused with 4% PFA. Spinal cords were removed and postfixed overnight in 4% PFA at 4°C. Tissue was cryoprotected in 30% sucrose for 2-5 nights, depending on age, embedded in O.C.T. embedding medium (Sakura Finetek USA), and sectioned on a cryostat (20 m; Leica CM1950, Leica-Microsystems). Sections were incubated with 5% normal donkey serum in 0.1 M PBS with 0.3% Triton X-100 for 60 min at room temperature (RT), and then incubated with primary antibodies overnight at 4°C, except for the AA3 antibody, which was incubated for 7 nights at 4°C or overnight at RT on E16.5 tissue. Sections were subsequently incubated with the appropriate fluorescently conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) for 1 h at RT before being stained with Hoechst (1:25,000 in 0.1 M PBS) and coverslipped with Fluoromount-G (SouthernBiotech).
In situ hybridization. Digoxigenin-labeled cRNA probes (sense and antisense) were prepared using T3-RNA or T7-RNA polymerase. The probe specific for PLP covered the full coding region (Sorg et al., 1987) . Fixation and hybridization of fresh frozen cryostat sections was performed as described previously (Fuss et al., 1997), with modifications. Briefly, 20 m cryostat sections were fixed in 4% PFA in PBS, pH 7.4, and then washed in PBS. Sections were treated with 5 g/ml proteinase K for 4 min, refixed in 4% PFA for 20 min, washed in PBS, and acetylated for 10 min. After acetylation, sections were prehybridized at 60°C in hybridization buffer (50% formamide, 5ϫ SSC, 50 ng/ml tRNA, 50 g/ml heparin, 1% SDS). Hybridization of probe (0.13 ng/ml in hybridization buffer) was performed at 60°C overnight. Sections were washed in prewarmed 5ϫ SSC for 30 min at RT, followed by washes in prewarmed 0.2ϫ SSC at 65°C. Bound cRNA was detected using an alkaline phosphatase-coupled antibody to digoxigenin with subsequent color development BM Purple Substrate (Roche Diagnostics).
Cell counts and measurements of process lengths and orientations. Spinal cord sections from wild-type and Plp1-null littermates were matched based on spinal cord segment, and tile-scan images were taken on a Leica SP5 confocal microscope with LAS software (Leica-Microsystems) using either a 25ϫ water-immersion objective (aperture 0.95) or a 40ϫ oilimmersion objective (aperture 0.75-1.25) at RT. Tile-scans were merged using the Mosaic Merge module of the LAS software to reconstruct each spinal cord section. Images were adjusted for contrast and brightness, and cropped in Photoshop (Adobe Systems). Annotations were made in Illustrator (Adobe Systems). For cell counts, images were opened in Fiji (Schindelin et al., 2012) and single-labeled, double-labeled, and triplelabeled cells were counted using the Cell Counter plugin (http://rsbweb. nih.gov/ij/plugins/cell-counter.html, Kurt De Vos). To measure processes, the six longest processes per region per section were measured with the Simple Neurite Tracer plugin (Longair et al., 2011) . Process orientation was measured only for bipolar cells from which both full processes could be accurately imaged. Orientation was considered tangential if parallel to midline, radial if the processes would eventually contact both the midline and the pial surface, and all other orientations were classified as "other" (Leber and Sanes, 1995). Measurements were made by a blinded observer. Western blotting. Spinal cord extracts were prepared in RIPA buffer containing 1% Triton X-100 with a protease inhibitor mixture (Roche). Proteins were quantified and analyzed by SDS-PAGE, after which proteins were transferred onto PVDF membrane and blocked for 1 h with 5% BSA in TBST. Primary antibodies [myelin basic protein (MBP), SMI94, 1:1000; Covance Research Products; PLP/DM20, clone AA3, 1:100; GAPDH, 14C10, 1:5000; ␤-tubulin, 1:5000; Cell Signaling Technology] were incubated with the membranes overnight at 4°C. Near-infrared fluorescent secondary antibodies (LI-COR Biosciences) were used at 1:10,000. Proteins were visualized on an Odyssey Infrared Imaging System (LI-COR). MBP levels were normalized to GAPDH or ␤-tubulin levels for each sample. Quantification was done on 3-5 cords at each time point and the normalized levels of MBP are presented as the mean Ϯ SEM.
Live imaging of OPC migration. OPCs derived from oligospheres were generated as previously described (Pedraza et al., 2008) . Chamber slides (iBidi) were coated with poly-D-lysine (10 g/ml; Sigma-Aldrich) for 1 h at 37°C, washed, and then coated in fibronectin (10 g/ml; EMD Millipore) overnight at 37°C. Oligospheres (passage 2-5) were dissociated using NeuroCult (Stem Cell Technologies), plated at a density of 30,000 cells per well in OPC media [DMEM:F12 (Invitrogen Life Technologies), 1ϫ B27 supplement (Invitrogen), PDGF, and FGF (10 ng/ml; Peprotech)], and incubated at 37°C for 24 h. Media was changed just before imaging. Imaging was conducted on an inverted Leica SP5 confocal microscope equipped with a LiveCell imaging chamber (Pathology Devices) for 11 h. Cells were manually tracked using the ImageJ plugin Manual Tracking (http://rsb.info.nih.gov/ij/plugins/track/track.html, Fabrice Cordelires). Tracks of individual cells were analyzed in the Chemotaxis and Migration Tool plugin for ImageJ (iBidi) to determine the average accumulated distance and velocity.
Statistical analysis. Cell counts were performed on Ն3 spinal cord sections from three wild-type and four Plp1-null embryos across two litters at E14.5, from six wild-type and five Plp1-null embryos across three litters at E16.5, and from five wild-type and four Plp1-null pups across three litters at postnatal day (P) 7. Process measurements were made on three wild-type and three Plp1-null animals at E16.5. Cell migration measurements where made on 291 wild-type cells and 231 Plp1-null cells, across four different experiments. Statistical analyses were performed using one-way ANOVA for group comparisons; a two-tailed, unpaired Student's t test for single comparisons; or a Mann-Whitney U test for population distributions using Prism 6 for Mac OS X (GraphPad Software); p values Ͻ0.05 were considered significant.
Results
In the spinal cord, PLP-EGFP-labeled cells in the ventricular zone/subventricular zone (VZ/SVZ) migrated laterally to populate the developing white mater PLP-EGFP mice were used to track the development of embryonic and postnatal spinal cord oligodendrocytes. In these mice, Plp1 promoter activity drives EGFP expression. At E12.5, robust EGFP expression was present in the VZ/SVZs that surround the central canal of the ventral spinal cord (Fig. 1A) . Cells in the ventral spinal cord went on to extend long processes toward the pial surface and migrate laterally (E16.5; Fig. 1B ) until they reached the presumptive white matter. By P7, PLP-EGFP expression increased dramatically in white matter regions of myelinated CNS axon tracts (Fig. 1C) . Strong transgene expression was also seen in the dorsal root ganglia (Fig.  1A ,B), which also express PLP (Wight et al., 1993; Mallon et al., 2002) . In situ hybridization of semiadjacent sections demonstrated that Plp/Dm20 mRNA was expressed in the same pattern as PLP-EGFP at E12.5 (D), E16.5 (E), and P7 (F). Although Plp/Dm20 transcripts have been found in the developing spinal cord (Timsit et al., 1992; Dickinson et al., 1996; and others) , PLP/DM20 protein has not been observed there. However, incubation of E16.5 sections with PLP/DM20 antibody (AA3) for 7 d at 4°C, or overnight at RT, allowed for detection of PLP/DM20 protein in multiprocessed PLP-EGFPϩ cells (Fig. 1G ). PLP/DM20 was located in OPC processes and cell bodies, as well as in the distal tips of OPC processes that did not contain the cytosolic EGFP (Fig. 1G, arrow) . This suggests that the difficulty in detecting PLP/DM20 protein in bipolar embryonic migratory cells may result from the localization of the protein to the distal tips of processes that cannot be definitively linked to specific cells.
PLP-EGFP-labeled precursors of multiple lineages are present in the VZ/SVZ of the E12.5 spinal cord
To identify the Plp1-expressing cells in the E12.5 VZ/SVZ, we studied the expression of markers for neuronal and glial precursors in PLP-EGFP embryos (Fig. 2) . Many PLP-EGFPϩ cells immediately adjacent to the central canal were immunopositive for Fig. 2A) , indicating that they were yet undifferentiated multipotent precursors (Avilion et al., 2003; Ellis et al., 2004; Masui et al., 2007) . A small group of Pax6-expressing cells, which give rise to ventral interneurons and motor neurons (Ericson et al., 1997) , partially overlapped with the PLP-EGFP domain. In particular, some Pax6ϩ/PLP-EGFPϩ cells (Fig. 2B, arrows) were at the dorsal-most limit of the PLP-EGFP domain of the VZ/SVZ. Because a subset of OPCs are known to express Nkx2.2 , we also examined Nkx2.2 expression. Although occasional Nkx2.2ϩ/PLP-EGFPϩ cells were seen in the VZ (Fig. 2C, arrow) , Nkx2.2ϩ cells were predominantly located outside of the PLP-EGFPexpressing domain. Olig2 expression was studied because OPCs arise from Olig2-expressing cells of the motor neuron progenitor (pMN) domain Park et al., 2002) . At E12.5, Olig2ϩ cells were concentrated in the VZ/SVZ of the pMN, and all were positive for PLP-EGFP ( Fig. 2D , arrows; Table 1 ). Another marker of OPCs, PDGFR␣, was expressed by a subset of cells delaminating out of the VZ, which were also positive for PLP-EGFP (Fig. 2E, arrows) . As reported previously (Delaunay et al., 2008) , Nestinϩ/PLP-EGFPϩ radial glia were also seen, with long processes that extended conical end feet to the pial surface (see Fig. 7 ). These cells are known to differentiate into astrocytes, with a small subset differentiating into oligodendrocytes (McMahon and McDermott, 2001; Fogarty et al., 2005; McDermott et al., 2005) .
Sox2 (
PLP-EGFP was expressed early and then downregulated by migratory OPCs before being upregulated during myelination At E14.5, PLP-EGFPϩ cells were still present in the ventral VZ surrounding the central canal. However, many PLP-EGFPϩ cells had migrated out of the SVZ into the dorsal and ventral intermediate zones (IZs) and they began to populate the lateral presumptive white matter (pWM; Fig. 3A ). In addition to the PLP-EGFPϩ cells in the ventral cord, PLP-EGFPϩ cells were in the VZ/SVZ of the dorsal cord at E14.5 as well (Fig.  3A) . At this stage, these PLP-EGFPϩ cells in the dorsal VZ did not label with Olig2 or PDGFR␣, but likely represent the OPC progenitors that arise later in the dorsal spinal cord (Fogarty et al., 2005; Vallstedt et al., 2005; . Around the central canal, many PLP-EGFPϩ cells continued to express Sox2 (Fig. 3B ), indicating that they remained undifferentiated precursors. All of the Olig2ϩ/PDGFR␣ϩ cells in the VZ were PLP-EGFPϩ and nearly all Olig2ϩ/PDGFR␣ϩ cells outside of the VZ/SVZ continued to express PLP-EGFP (Fig. 3C ,D, white arrows; Table 1 ). Some PLP-EGFPϩ cells in the IZ were negative for both Olig2 and PDGFR␣ (Fig. 3 D, E) . These cells may represent early progenitors outside of the oligodendrocyte lineage, e.g., neurons and astrocytes, a small percentage of which also express the Plp1 promoter (see Figs. 5, 6 ). Many PLP-EGFPϩ cells at this stage were proliferative, as determined by Ki67 immunostaining (data not shown).
At E16.5, cells continued to migrate laterally away from the VZ/SVZ (Fig. 4A) . Although many Olig2ϩ/PDGFR␣ϩ OPCs throughout the dorsal (Fig. 4B ) and ventral spinal cord (Fig. 4D) continued to express PLP-EGFP (Fig. 4B-D , single-headed arrows), there were also Olig2ϩ/PDGFR␣ϩ OPCs that no longer expressed PLP-EGFP (Fig. 4B-D , double-headed arrows), particularly in the lateral pWM. Very few Olig2ϩ cells remained in the VZ (Fig. 4C ). While we were not able to follow the fate of individual PLP-EGFPϩ cells over time, our analysis suggests that as OPCs arise from the VZ, they first express PLP-EGFP before expressing Olig2 and PDGFR␣. Olig2 expression was maintained and PDGFR␣ expression increased as PLP-EGFP-expressing OPCs moved away from the SVZ. OPCs farther away from the VZ decreased PLP-EGFP expression, until finally Olig2ϩ/ PDGFR␣ϩ OPCs no longer expressed PLP-EGFP.
By P7, OPCs in white matter regions had matured into myelinating oligodendrocytes that expressed high amounts of PLP-EGFP (Fig. 4 E, F ) and MBP (Fig. 4F ) . At this stage, myelinating oligodendrocytes were present throughout the lateral white matter as well as the gray matter of the spinal cord, and these Olig2ϩ oligodendrocytes expressed intense PLP-EGFP (Fig. 4E , inset). In the gray matter, Olig2ϩ/PDGFR␣ϩ OPCs were present and many were PLP-EGFP-negative (Fig. 4E) . Some Olig2ϩ/ PDGFR␣ϩ OPCs did express PLP-EGFP in their cell bodies, but at very low levels compared with myelinating (MBPϩ) oligodendrocytes (Fig. 4F , Table 1 ). Low-level expression of PLP-EGFP in postnatal OPCs could be residual from earlier expression or the beginning of upregulation of Plp activity in preparation for myelination. Collectively, our analysis of PLP-EGFP expression in the developing spinal cord suggests that the Plp1 gene is expressed by early progenitors and migrating OPCs. OPCs then downregulate Plp1 until they mature into myelinating oligodendrocytes, at which time they dramatically upregulate Plp1 as they myelinate axons.
In the developing spinal cord, PLP-EGFP was expressed by neurons and astrocytes PLP-EGFP was also seen in progenitor cell populations other than developing oligodendrocytes (Table 1 ). In agreement with Delaunay et al., (2008) , PLP-EGFP expression was detected in a small subset of NeuNϩ neurons (Fig. 5A ) in the ventral horn at E14.5. PLP-EGFP intensity was much lower in neurons (Fig. 5A , inset, arrow) than in OPCs (Figs. 3, 4) , suggesting that neurons were downregulating Plp1. Although rare, PLP-EGFPϩ neurons (Fig. 5B , inset, arrow) were still seen occasionally in the spinal cord at P7, but PLP was not detected in these cells (data not shown). PLP-EGFP expression was also observed in immature GFAPϩ astrocytes at E16.5 (Fig. 6A-D) . At E16.5, PLP-EGFP was seen in both bipolar migratory astrocytes near the lateral white matter (Fig. 6B , arrowheads) and in process-bearing astrocytes in the gray matter (Fig. 6C , arrowheads). PLP, as detected by the AA3 antibody, was not detected in astrocytes, but was confined to multiprocess-bearing OPCs in the ventral white matter (Fig. 6D , double-headed arrows) and dorsal columns. By P7, many GFAPϩ astrocytes no longer expressed PLP-EGFPϩ (Fig.  6E-G) . In GFAPϩ astrocytes that did continue to express PLP-EGFP (Fig.  6 F, G, arrowheads) , the intensity of EGFP was much lower than in neighboring oligodendrocytes (Fig. 6F , double-headed arrows), and PLP-EGFP was confined to the soma, suggesting that astrocytes were downregulating PLP promoter activity as they matured. We quantified the number of GFAPϩ astrocytes expressing PLP-EGFP and found a surprising number of astrocytes labeled with PLP-EGFP: ϳ40% at E16.5 and 25% at P7 (Table 1) . We also used S100␤ϩ, which labels immature astrocytes and subtypes of mature astrocytes (Wang and Bordey, 2008) , to identify cell bodies of GFAPϩ astrocytes (data not shown). Because cells of the oligodendrocyte lineage can also express S100␤ (Deloulme et al., 2004) , only S100␤ϩ cells that were negative for Olig2 were counted as astrocytes. We found that although S100␤ only labeled ϳ13% of the astrocytes at E16.5, nearly all S100␤ϩ/GFAPϩ astrocytes (96.4 Ϯ 3.7%) expressed PLP-EGFP. At P7 only 35.7 Ϯ 7.5% of the S100␤ϩ astrocytes had detectable PLP-EGFP in their cell bodies. Intriguingly, it appears that the subset of astrocytes that express S100␤ in the embryo express the greatest amount of PLP-EGFP, which is consistent with the concept that PLP-EGFP is expressed in immature cells, such as immature astrocytes that express S100␤ϩ (Wang and Bordey, 2008) . Importantly, PLP was not detected in astrocytes at either E16.5 (Fig. 6A-D) or P7 (Fig. 6 E, F ) , suggesting that residual EGFP label was from earlier plp/dm20 promoter activity. These results indicated that although the plp/dm20 promoter is active in neuron and astrocyte progenitors, it diminishes with development; PLP is not produced in these cell types but rather is restricted to cells of the oligodendroglial lineage. Oligodendrocyte progenitor cells downregulated PLP-EGFP expression as they migrated laterally at E16.5 and in the P7 cord. A, PLP-EGFP expression (green) in the cervical spinal cord at E16.5. B, In the dorsal cord, some Olig2ϩ/PDGFR␣ϩ OPCs no longer express PLP-EGFP (double-headed arrows) while others continued to express PLP-EGFP (single-headed arrows). C,Inthe VZ, fewer cells expressed PLP-EGFP at E16.5. Within the IZ, many Olig2ϩ/PDGFR␣ϩ OPCs expressed PLP-EGFP (single-headed arrows), while more laterally located OPCs were PLP-EGFP-negative (double-headed arrows). D, In the pWM, no PLP-EGFP expression was seen in the most lateral Olig2ϩ/PDGFR␣ϩ OPCs (double-headed arrows). E, Many PDGFR␣ϩ (blue) and Olig2ϩ (red) OPCs in the gray matter were PLP-EGFP-negative or expressed very low levels of PLP-EGFP (arrows), while myelinating oligodendrocytes had robust PLP-EGFP expression and nuclear Olig2 expression (red, inset). F, PLP-EGFP colocalized with MBP expression (red), indicating these cells are mature myelinating oligodendrocytes. Scale bars: A, 100 m; B-D, 50 m; E, inset, 10 m; F, 50 m.
OPC development in Plp1-null mice Due to the high levels of Plp1 promoter activity seen in migratory neuronal, oligodendroglial, and astroglial progenitors, it was tempting to speculate that PLP/DM20 may serve a role in progenitor cell migration. To examine the role of PLP/DM20 in the migration and development of oligodendrocytes, the PLP-EGFP reporter (Mallon et al., 2002) was crossed into mice carrying the Plp1-null allele . OPC generation, process extension, and migration were examined in vivo at E12.5, E14.5, E16.5, and P7 in both Plp1-null PLP-EGFP and wild-type PLP-EGFP male littermates. At E12.5, PLP-EGFP-expressing cells arose comparably in the ventral VZ of both wild-type and Plp1-null mice, and PLP-EGFPϩ processes emanated radially from these VZ/ SVZ cells (Fig. 7) . As in wild-type mice (Fig. 7A) , Nestinϩ radial glia in Plp1-null mice extended processes from the VZ, and radial glia end feet appeared to contact the pial surface normally (Fig. 7B) . In both wild-type (Fig. 7C) and Plp1-null (Fig. 7D) spinal cords, PDGFR␣-expressing cells arose from the ventral VZ in the same spatiotemporal manner.
We next looked at the distribution of OPCs in the dorsal and ventral spinal cord in wild-type and Plp1-null mice at E14.5 and at E16.5. No differences in the total number of Olig2ϩ/ PDGFR␣ϩ OPCs or their distribution throughout the dorsal and ventral cord were seen at either E14.5 (data not shown) or E16.5 (Fig. 8) . Intriguingly, in wild-type mice, PLP-EGFPϩ cells emanated long processes from the SVZ that were radially oriented (Fig. 8A) , while PLP-EGFPϩ processes in Plp1-null mice appeared shorter and much more disorganized (Fig. 8B) . To analyze the organization of process extension, the orientation of PLP-EGFPϩ processes was determined and classified as tangential, radial, or other (i.e., random; see Materials and Methods). Plp1-null mice had a significant increase in the number of cell processes with other orientations compared with wild-type mice ( p ϭ 0.013, t test, two-tailed; Fig. 8D ). Measurements of the PLP-EGFPϩ process lengths were made in both the ventral and dorsal regions of the spinal cord (Fig. 8E) . Interestingly, PLP-EGFPϩ processes in the ventral region of the E16.5 cord were much longer than PLP-EGFPϩ processes in the dorsal region of the cord. Within the ventral cord, the PLP-EGFPϩ processes were significantly shorter in Plp1-null mice, compared with wild type (Fig. 8E) . No significant difference was seen in the lengths of dorsal PLP-EGFPϩ processes between Plp1-null and wild-type mice. Despite the differences in process length, the total number of Olig2ϩ/PDGFR␣ϩ OPCs in different regions of the ventral and dorsal cord, as well as their overall distribution, was similar in both wild-type and Plp1-null mice at E16.5 (Fig. 8C) .
We have previously shown that PLP forms complexes with membrane receptors, including ␣ v integrin, to influence OPC migration on fibronectin (Gudz et al., 2002 (Gudz et al., , 2006 . Fibronectin is expressed along radial glial processes (Sheppard et al., 1995; Stettler and Galileo, 2004) , and thus could be a substrate along which neurons and glial cells migrate in vivo. We analyzed the migration of OPCs generated from both wild-type and Plp1-null neurospheres (Fig. 8 F, G) using live imaging analysis of OPC migration on fibronectin-coated chamber slides. Cells were tracked and the velocity and distance of migration were quantified with the Chemotaxis and Migration Plugin (iBidi). We generated frequency histograms to determine the distributions of cell velocities (Fig.  8F ) and accumulated distances (Fig. 8G) within the populations of wild-type and Plp1-null cells. For velocity, the medians of wildtype and Plp1-null cells were 0.179 and 0.202 m/min respectively, and the median distances traveled were 107.8 m (wild type) and 125.8 m (Plp1-null). We ran a Mann-Whitney's U test to evaluate the difference in the migration velocities and accumulated distances between wild-type and Plp1 cells. We found that Plp1-null cells were significantly faster ( p ϭ 0.0041) and migrated farther ( p ϭ 0.0006) than wild-type cells on fibronectin. Studies to understand the mechanisms underlying these differences are ongoing.
Despite the absence of the major myelin protein, Plp1-null mice are still able to myelinate axons and produce compact myelin around axons Griffiths et al., 1998; Jurevics et al., 2003) . To assess whether the absence of PLP impacts the onset of myelination in Plp1-null mice, spinal cords from early postnatal mice were examined by immunohistochemistry and Western blot for PLP and MBP (Fig. 9) . By P7, robust PLP expression throughout the cord overlapped with PLP-EGFP expression (Fig. 9A) . EGFP filled the entire cell body and many of the larger processes of oligodendrocytes, while PLP was in processes, but mostly excluded from oligodendrocyte cell bodies. As expected, no PLP immunoreactivity was seen in Plp1-null cords by immunostaining (Fig. 9B) or Western blot (Fig. 9E ), but MBP expression overlapped PLP-EGFP expression in both wild-type (Fig. 9C) and Plp1-null cords (Fig. 9D) . The total numbers of oligodendrocytes and OPCs throughout the cord were unchanged in Plp1-null mice at P7 compared with wild type (data not shown). Given the expression of PLP-EGFP outside of the oligodendroglial lineage, we counted total numbers of astrocytes and neurons in wild-type and Plp1-null cords at P7, and found no change in Plp1-null animals (data not shown). We also examined glial activation of GFAPϩ astrocytes and Iba1ϩ microglia (data not shown), and these were similarly unchanged in Plp1-null mice compared with wild type. Quantification of MBP levels by Western blots of Plp1-null and wild-type spinal cord lysates re- vealed no change in MBP expression at P4 (data not shown) or P7 (Fig. 9E) .
Discussion
These studies demonstrated that Plp1 promoter activity in the spinal cord was biphasic, first occurring very early in the embryonic neuroepithelium and then again postnatally in myelinating oligodendrocytes. PLP-EGFP was expressed in undifferentiated precursors of the spinal cord as well as by neuronal, astroglial, and oligodendroglial progenitors. Within the oligodendroglial lineage, PLP-EGFP expression was very dynamic. Initially, in the ventral VZ, all Olig2ϩ/PDGFR␣ϩ OPCs expressed PLP-EGFP. Olig2ϩ/ PDGFR␣ϩ cells lost PLP-EGFP expression as they migrated laterally toward the pWM. PLP-EGFP remained downregulated in postnatal OPCs, while myelinating oligodendrocytes strongly upregulated PLP-EGFP. Biphasic activity of the Plp promoter was also reported in Plp-cre;Z/EG mice in which the lag between Crerecombinase expression and recombination leading to GFP expression could be used to identify earlier-born and later-born cells (Delaunay et al., 2008) . Our data suggest that oligodendrocytes in the spinal cord arise from a single cell lineage, with differential expression of PLP/DM20 and PDGFR␣ at distinct stages. The biphasic expression of PLP-EGFP could explain some of the past controversy regarding the origin of OPCs (Spassky et al., 1998; 2000; Richardson et al., 2000) . Previous reports found Pdgfr␣ transcripts in cells that were Plp1-negative and proposed that these cells were of two separate OPC lineages. Given the low levels of Plp1 mRNA and protein at embryonic stages (Ivanova et al., 2003; this study) , it may be difficult to detect them directly. Using the Plp1 promoter and 3ЈUTR to drive high levels of EGFP, we were able to clearly identify Plp1 promoter activity in many embryonic cells. Our results suggest that because of the biphasic expression of PLP-EGFP, the embryonic PDGFR␣ϩ population that was positive for PLP-EGFP was less differentiated than the PDGFR␣ϩ OPCs that were PLP-EGFP-negative. It is possible that the PLP-EGFP-negative OPCs might never have expressed PLP-EGFP, and migrated out earlier than the PLP-EGFP population. However, this is unlikely since at the earliest stages examined all Olig2ϩ/PDGFR␣ϩ cells in the VZ/SVZ were PLP-EGFPϩ. Given that PLP and GFP may have different half lives within the same cell (Delaunay et al., 2008, their Discussion) , it is possible that some EGFPϩ cells may no longer be producing PLP. In fact we were unable to detect PLP in PLP-EGFP-labeled neurons or astrocytes. However we have shown that at both E16.5 and P7, PLP is present in the processes of PLP-EGFP-expressing OPCs. At later stages, PLP, but not DM20, continues to be expressed by a subset of NG2ϩ cells in the brain (Mallon et al., 2002; Ye et al., 2003) , which presumably give rise to myelinating oligodendrocytes.
In the absence of PLP expression, there was mild disruption of process extension in ventral PLP-EGFP-expressing cells; processes were shorter and often disorganized, with fewer processes aligned radially. Despite abnormal process development, no differences in OPC numbers, distribution, or onset of myelination were seen in Plp1-null spinal cords. Within the spinal cord, OPCs arise from either the ventral or dorsal regions. The generation of ventrally derived OPCs is dependent on Sonic hedgehog (Shh), while dorsal OPCs arise independently of Shh signaling, possibly dependent on fibroblast growth factor or bone morphogenic factor instead (for review, see Richardson et al., 2006) . Ventrally and dorsally derived oligodendrocytes preferentially myelinate differ- C, arrowheads) . E, At P7, very low levels of PLP-EGFP were seen in a fraction of GFAPϩ (red) astrocytes (F, G, arrowheads), although PLP-EGFP levels were much higher in oligodendrocytes (F, double-headed arrows) that also expressed PLP (blue). E-G, Some astrocytes (E) expressed low levels of PLP-EGFP in their cell bodies (F, G, arrowheads) although many astrocytes were not GFPϩ, and no astrocytes expressed PLP (blue). Dashed boxes in A and E depict regions of shown in B-D and F-G. Scale bars: A, E, 100 m; (in G) B-D, F, G, 10 m. ent tracts in both the brain and spinal cord (Tripathi et al., 2011) ; furthermore, dorsally derived oligodendrocytes are more likely to repopulate lesions and remyelinate axons after focal demyelination (Zhu et al., 2011) . Although we could not distinctly fate-map dorsally versus ventrally derived OPCs in our PLP-EGFP mice, we did see PLP-EGFP expression in both populations. The ventrally derived PLP-EGFPϩ cells displayed shorter processes in Plp1-null mice, while the dorsally derived PLP-EGFPϩ cells did not, suggesting that these two populations respond to different environmental cues to regulate process extension.
At E12.5, many PLP-EGFPϩ cells in the VZ were outside of the pMN domain, from which Olig2ϩ cells arise. Cells from a variety of lineages expressed PLP-EGFP, including neurons (Pax6), oligodendrocytes and motor neurons (Olig2ϩ), and unspecified precursors (Sox2). As in other studies (Delaunay et al., 2008; Guo et al., 2009; Michalski et al., 2011) , we found that the Plp1 promoter was active in neurons and astrocytes. Our findings that ϳ25% of the GFAPϩ astrocytes at P7 are labeled with PLP-EGFP are very consistent with the findings of other groups that used the PLP promoter to label cells in the CNS (Guo et al., 2009; Michalski et al., 2011; PLP-CreER T2 ; PLP-CreERT2; and PLPCre). They reported that 33% of astrocytes in the P4 spinal cord (Michalski et al., 2011), 12% of astrocytes in the P15 spinal cord (Guo et al., 2009), and 11% in the P28 spinal cord (Michalski et al., 2011) had PLP promoter activity. The downregulation of PLP-EGFP and the absence of PLP in neurons and astrocytes indicate that many of the early PLP-EGFP-expressing cells in the VZ downregulate PLP-EGFP and adopt nonoligodendroglial cell fates. This expression pattern raises the question of whether PLP/ DM20 plays a role in specifying oligodendroglial versus astroglial or neuronal cell identity, in addition to its role in myelination. To determine whether PLP/DM20 regulated precursor fate specification, total numbers of neurons, astrocytes, and oligodendrocytes, as well as the percentage that expressed PLP-EGFP, were assessed in both wild-type and Plp1-null spinal cords. We did not detect any differences in the numbers of astrocytes, neurons, oligodendrocytes, or their distributions throughout the cord, indicating that PLP/DM20 was not essential for cell fate specification, survival, or migration. In vitro studies have reported that reduced levels of PLP can reduce apoptosis and increase oligodendrocyte cell survival, and cultures from Plp1-null mice produce twice as many oligodendrocytes as cultures from wild-type mice (Skoff et al., 2004) . We saw no changes in OPC numbers in our studies, nor have other studies of Plp1-null mice reported such increases, but it may be that in vivo there is not enough trophic support for excess oligodendrocytes, keeping numbers constant.
The dynamic expression of the Plp1 promoter, high in early progenitors, low at intermediate stages, and then high again postnatally, suggests two roles for PLP: an early role in migratory progenitors, followed by a later role in mature oligodendrocytes during myelination. However, the question of PLP's role in nonmyelinating cell types persists. PLP/DM20 proteins resemble the tetraspanins (Boucheix and Rubinstein, 2001; Rubinstein, 2011) and our previous in vitro studies indicate PLP may function similarly by providing a nucleating scaffold that enables the interaction of other proteins, including integrins, thereby integrating extracellular signaling and intracellular pathway activation (Gudz et al., 2002 (Gudz et al., , 2006 . PLP-EGFPϩ cell processes in the ventral spinal cord of Plp1-null mice had shorter and often disorganized processes relative to wild-type controls, supporting a role for PLP signaling in migration and/or process extension. In live imaging studies of OPC migration on fibronectin, a ligand for ␣ v integrins, Plp1-null OPCs migrated faster and farther than wildtype OPCs. PLP can form a complex with ␣ v integrin and GluR2, an AMPA receptor subunit, and the association of PLP with ␣ v integrin increases upon stimulation with glutamate or glutamate agonist (Gudz et al., 2002 (Gudz et al., , 2006 . Although in the current study we did not stimulate cells in our live imaging migration assays, there may be, in the absence of PLP, reduced clustering of integrins in OPCs on fibronectin, causing decreased binding and increased migration speed. While our in vivo results indicate PLP/ DM20 is nonessential for OPC migration and developmental myelination, it could be important in the context of adult remyelination after injury. After focal demyelination in the adult mouse corpus callosum, OPCs migrating from the SVZ have been shown to form functional glutamatergic synapses with demyelinated axons (Etxeberria et al., 2010) . Whether Plp1-null OPCs would be able to make such connections and effectively remyelinate demyelinated axons remains unknown.
Other in vitro studies also suggest a role for PLP in OPC process extension. For example, PLP antisense treatment of OPCs results in abnormal process development and reduced membrane formation (Yang and Skoff, 1997) , while overexpression of PLP in Oli-Neu cells results in increased process extension and branching (Werner et al., 2013) . Despite the process abnormalities of Plp1-null OPCs, we did not see any dramatic differences in the distribution of OPCs throughout the developing spinal cords of Plp1-null mice. Redundant mechanisms in OPC development may exist such that OPC migration and myelination were minimally disrupted. Indeed, in the absence of PLP, expression of a PLP-homolog, glycoprotein M6B, is increased and able to partially compensate for the loss of PLP during myelination (Werner et al., 2013) .
Although its role in OPC migration and myelination appears dispensable, PLP clearly has an important role in supporting normal axonal function. Plp1-null animals generate normal numbers of oligodendrocytes and produce compact myelin that contacts and wraps axons, but over time develop axonal swellings, problems with retrograde axonal transport, and eventual axonal degeneration (Boison and Stoffel, 1994; Rosenbluth et al., 1996; Griffiths et al., 1998; Yool et al., 2001) . PLP is necessary for the transport of certain proteins, such as the NAD ϩ -dependent deacetylase, sirtuin 2, and cholesterol into CNS myelin, and PLP-deficient myelin has reduced cholesterol content (Krämer-Albers et al., 2006; Werner et al., 2007 Werner et al., , 2013 . PLP is in exosomes released by oligodendrocytes, which can be taken up by neurons and other glia Fitzner et al., 2011; Frühbeis et al., 2013) . The axonal degeneration seen in Plp1-null mice likely results from a loss of trophic or metabolic support, either from altered myelin structural integrity, perturbed exosome trafficking, or an as yet undefined form of oligodendrocyte-axonal communication. Future studies on interactions between oligodendrocytes and neurons in Plp1-null animals may reveal additional undiscovered roles for PLP. wild-type and Plp1-null spinal cord lysates for PLP/DM20, MBP, and ␤-tubulin. Quantification of MBP levels normalized to ␤-tubulin was similar between wild-type and Plp1-null mice at P7. n.s., Not significantly different.
